Multimarker Approach to Identify Patients with Coronary Artery Disease at High Risk for Subsequent Cardiac Adverse Events: The Multi-Biomarker Study.

Biomolecules · 2020 · PMC7356937 · PMID 32549327

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Beside the significantly elevated NT-proBNP value in the AMI group, from the 7 new biomarkers, only suPAR showed a trend towards higher value in the AMI group. 4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.